The Virginia Commonwealth University (VCU) IMSD program as prompted by a self-study which indicated that significant percentages of underrepresented minority (URM) VCU undergraduate Biology majors and PhD students in the biomedical sciences are underperforming in their academic programs. Although more than 1/3 of VCU freshman and sophomore Biology majors are URM, ~40% of these individuals drop out of the Biology major due to poor performance in gatekeeper courses. The VCU School of Medicine (SOM) matriculates and graduates PhD students at rates that are comparable to the national average, but these individuals take longer to graduate and are less productive (fewer first and co-author papers) than are their majority peers. To address these disparities, we propose a two-phase, comprehensive research and education program intended to provide URM undergraduate and PhD students with the theoretical background, technical skills, critical thinking/ problem solving abilities, confidence, and determination necessary to succeed in careers in research. The VCU IMSD program takes advantage of existing resources, builds on existing successful models, and incorporates novel strategies to intervene with """"""""at risk"""""""" students. The undergraduate phase of VCU IMSD will target 16 talented Biology students for participation in a program that provides (a) highly-structured courses intended to incrementally introduce students to basic concepts in biomedical research, (b) an early and intensive mentored research experience followed by a 2-year independent research project, (c) a """"""""Learning Community"""""""" of like-minded scholars, intended to envelope IMSD Scholars in a atmosphere of continuous learning and personal/ professional development, and (d) a variety of enrichment activities providing opportunities to practice oral and written presentation skills, counseling in preparation of graduate school applications, and development of skills sets necessary for success on standardized exams. The PhD phase of the IMSD program will be admit two IMSD Predocs/ year who will participate in (a) a """"""""pre-matriculation"""""""" summer program that provides courses in Critical Scientific Thinking and basic Biochemistry, Cell and Molecular Biology and a highly mentored research experience, (b) a reduced course load that offers the option of completing the first year of PhD courses over the course of two years, and (c) enrichment activities that stress the development of critical thinking/ problem solving capacities, offer opportunities to develop communications skills, and provide networking opportunities intended to build confidence, establish self- efficacy, and promote the independence that is necessary to be productive in research. We strongly believe that the VCU IMSD program will not only ensure IMSD-supported students'commitment and completion of the PhD in biomedical sciences but that the enthusiasm and passion of IMSD students will impact on their non- supported peers and spark their interest in biomedical research as well.

Public Health Relevance

The future of medicine depends on biomedical research and the new discoveries that research brings to disease mechanisms. However, disparities exist, not only in healthcare and disease but also in the researchers who push biomedicine forward. The VCU-IMSD program is intended to address this disparity by increasing the number of underrepresented minorities who pursue PhD level training in biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Education Projects (R25)
Project #
5R25GM090084-03
Application #
8242754
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Janes, Daniel E
Project Start
2010-03-15
Project End
2014-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
3
Fiscal Year
2012
Total Cost
$216,710
Indirect Cost
$14,161
Name
Virginia Commonwealth University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Mehta, Rohini; Shaw, Gladys; Masschelin, Peter et al. (2018) Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH). PLoS One 13:e0199294
Conley, Sabena M; Abais, Justine M; Boini, Krishna M et al. (2017) Inflammasome Activation in Chronic Glomerular Diseases. Curr Drug Targets 18:1019-1029
Kang, Minho; Mischel, Ryan A; Bhave, Sukhada et al. (2017) The effect of gut microbiome on tolerance to morphine mediated antinociception in mice. Sci Rep 7:42658
Griggs, Lauren A; Hassan, Nadiah T; Malik, Roshni S et al. (2017) Fibronectin fibrils regulate TGF-?1-induced Epithelial-Mesenchymal Transition. Matrix Biol 60-61:157-175
Bowers, M S; Jackson, A; Maldoon, P P et al. (2016) N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice. Psychopharmacology (Berl) 233:995-1003
Kolawole, Elizabeth Motunrayo; McLeod, Jamie Josephine Avila; Ndaw, Victor et al. (2016) Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects. J Immunol 196:1461-70
Seashols-Williams, Sarah; Lewis, Carolyn; Calloway, Chelsea et al. (2016) High-throughput miRNA sequencing and identification of biomarkers for forensically relevant biological fluids. Electrophoresis 37:2780-2788
Guedia, Joy; Brun, Paola; Bhave, Sukhada et al. (2016) HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system. Sci Rep 6:31203
Owens, Robert A; Ignatowska-Jankowska, Bogna; Mustafa, Mohammed et al. (2016) Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice. J Pharmacol Exp Ther 358:306-14
Enga, Rachel M; Jackson, Asti; Damaj, M Imad et al. (2016) Oxycodone physical dependence and its oral self-administration in C57BL/6J mice. Eur J Pharmacol 789:75-80

Showing the most recent 10 out of 31 publications